INDICATED FOR THE INHIBITION OF PREMATURE LH SURGES IN WOMEN UNDERGOING CONTROLLED OVARIAN HYPERSTIMULATION.
AFTER INITIATING FSH THERAPY ON DAY 2 OR 3 OF THE CYCLE, GANIRELIX ACETATE INJECTION, 250 ?G MAY BE ADMINISTERED SUBCUTANEOUSLY, PREFERABLY INTO THE UPPER LEG (ROTATE INJECTION SITES TO PREVENT LIPOATROPHY),ONCE DAILY DURING THE MID TO LATE PORTION OF THE FOLLICULAR PHASE STARTING ON DAY 6 OF OVARIAN STIMULATION WITH GONADOTROPHINS . TREATMENT WITH GANIRELIX ACETATE SHOULD BE CONTINUED DAILY UNTIL THE DAY OF HCG ADMINISTRATION. WHEN A SUFFICIENT NUMBER OF FOLLICLES OF ADEQUATE SIZE ARE PRESENT, AS ASSESSED BY ULTRASOUND, FINAL MATURATION OF FOLLICLES IS INDUCED BY ADMINISTERING HCG. THE ADMINISTRATION OF HCG SHOULD BE WITHHELD IN CASES WHERE THE OVARIES ARE ABNORMALLY ENLARGED ON THE LAST DAY OF FSH THERAPY TO REDUCE THE CHANCE OF DEVELOPING OHSS (OVARIAN HYPERSTIMULATION SYNDROME).